{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:45:20Z","timestamp":1789757120288,"version":"4.0.1"},"reference-count":57,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.8378","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T20:03:39Z","timestamp":1458936219000},"page":"26346-26360","source":"Crossref","is-referenced-by-count":20,"title":["A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Burcu","family":"Yigit","sequence":"first","affiliation":[{"name":"Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Halibozek","sequence":"additional","affiliation":[{"name":"Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Shih","family":"Chen","sequence":"additional","affiliation":[{"name":"Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"O\u2019Keeffe","sequence":"additional","affiliation":[{"name":"Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Arnason","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Avigan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Bhan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Cen","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Longnecker","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[{"name":"Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Manhasset, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghai","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Engel","sequence":"additional","affiliation":[{"name":"Immunology Unit, Department of Cell Biology, Immunology and Neurosciences, Medical School, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cox","family":"Terhorst","sequence":"additional","affiliation":[{"name":"Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Ferrarini","year":"2005","journal-title":"The New England journal of medicine"},{"key":"2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Chiorazzi","year":"2013","journal-title":"Trends in immunology"},{"key":"3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1078-0432.CCR-13-0226","article-title":"Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia--focus on the B-cell receptor","volume":"20","author":"Burger","year":"2014","journal-title":"Clinical cancer research"},{"key":"4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Gribben","year":"2014","journal-title":"Seminars in cancer biology"},{"key":"5","first-page":"3","article-title":"Cell Trafficking in Chronic Lymphocytic Leukemia","author":"Burger","year":"2012","journal-title":"Open journal of hematology"},{"key":"6","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Kipps","year":"2000","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Rosenwald","year":"2009","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burger","year":"2007","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/onc.2013.31","article-title":"CD84 is a survival receptor for CLL cells","volume":"33","author":"Shachar","year":"2014","journal-title":"Oncogene"},{"key":"10","first-page":"181","article-title":"SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response","volume":"126","author":"Deaglio","year":"2016","journal-title":"The Journal of clinical investigation"},{"key":"11","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","article-title":"IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival","volume":"104","author":"Shachar","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2007.06569.x","article-title":"The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics","volume":"137","author":"Palencia","year":"2007","journal-title":"British journal of haematology"},{"key":"13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/smim.2000.0217","article-title":"The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells","volume":"12","author":"Lanier","year":"2000","journal-title":"Seminars in immunology"},{"key":"14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002510100337","article-title":"CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells","volume":"53","author":"Terhorst","year":"2001","journal-title":"Immunogenetics"},{"key":"15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1182\/blood.V90.6.2398","article-title":"CD84 leukocyte antigen is a new member of the Ig superfamily","volume":"90","author":"Engel","year":"1997","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s002510000252","article-title":"Ly108: a new member of the mouse CD2 family of cell surface proteins","volume":"52","author":"Ruley","year":"2000","journal-title":"Immunogenetics"},{"key":"17","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.4049\/jimmunol.1102620","article-title":"Cutting edge: Slamf8 is a negative regulator of Nox2 activity in macrophages","volume":"188","author":"Terhorst","year":"2012","journal-title":"Journal of immunology"},{"key":"18","first-page":"822s","article-title":"Genetic approach to insight into the immunobiology of human dendritic cells and identification of CD84-H1, a novel CD84 homologue","volume":"7","author":"Cao","year":"2001","journal-title":"Clinical cancer research"},{"key":"19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1202","article-title":"The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease","volume":"3","author":"Terhorst","year":"2003","journal-title":"Nature reviews Immunology"},{"key":"20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2776(08)00004-7","article-title":"The SLAM and SAP gene families control innate and adaptive immune responses","volume":"97","author":"Terhorst","year":"2008","journal-title":"Advances in immunology"},{"key":"21","doi-asserted-by":"crossref","first-page":"e28277","DOI":"10.1371\/journal.pone.0028277","article-title":"A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia","volume":"6","author":"Abruzzo","year":"2011","journal-title":"PloS one"},{"key":"22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.imlet.2010.09.017","article-title":"Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia","volume":"134","author":"Gattei","year":"2011","journal-title":"Immunology letters"},{"key":"23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Terhorst","year":"1998","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1093\/emboj\/20.21.5840","article-title":"Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells","volume":"20","author":"Terhorst","year":"2001","journal-title":"The EMBO journal"},{"key":"25","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.4049\/jimmunol.1001974","article-title":"Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL\/6 mouse","volume":"185","author":"Terhorst","year":"2010","journal-title":"Journal of immunology"},{"key":"26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.20101653","article-title":"A novel isoform of the Ly108 gene ameliorates murine lupus","volume":"208","author":"Morel","year":"2011","journal-title":"The Journal of experimental medicine"},{"key":"27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2012.05.016","article-title":"The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development","volume":"36","author":"Crotty","year":"2012","journal-title":"Immunity"},{"key":"28","first-page":"158","article-title":"Negative regulation of humoral immunity due to interplay between the SLAMF1, SLAMF5, and SLAMF6 receptors","volume":"6","author":"Terhorst","year":"2015","journal-title":"Front Immunol"},{"key":"29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2007.08.020","article-title":"Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development","volume":"27","author":"Bendelac","year":"2007","journal-title":"Immunity"},{"key":"30","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.4049\/jimmunol.174.10.5931","article-title":"Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions","volume":"174","author":"Terhorst","year":"2005","journal-title":"Journal of immunology"},{"key":"31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.1102773","article-title":"Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation","volume":"188","author":"Tsokos","year":"2012","journal-title":"Journal of immunology"},{"key":"32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1126\/science.1125893","article-title":"Regulation of B cell tolerance by the lupus susceptibility gene Ly108","volume":"312","author":"Mohan","year":"2006","journal-title":"Science"},{"key":"33","doi-asserted-by":"crossref","first-page":"E1500","DOI":"10.1073\/pnas.1300616110","article-title":"Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling","volume":"110","author":"Chiorazzi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2014-05-577122","article-title":"Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy","volume":"124","author":"Klein","year":"2014","journal-title":"Blood"},{"key":"35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1535-7163.MCT-10-0833","article-title":"Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma","volume":"10","author":"Longnecker","year":"2011","journal-title":"Molecular cancer therapeutics"},{"key":"36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Caligaris-Cappio","year":"1999","journal-title":"Leukemia research"},{"key":"37","doi-asserted-by":"crossref","first-page":"e76607","DOI":"10.1371\/journal.pone.0076607","article-title":"Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease","volume":"8","author":"Croce","year":"2013","journal-title":"PloS one"},{"key":"38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.imlet.2010.09.021","article-title":"Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells","volume":"134","author":"Engel","year":"2011","journal-title":"Immunology letters"},{"key":"39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2009.03.014","article-title":"Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens","volume":"30","author":"Randall","year":"2009","journal-title":"Immunity"},{"key":"40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/eji.1830180221","article-title":"The half-lives of serum immunoglobulins in adult mice","volume":"18","author":"Rajewsky","year":"1988","journal-title":"European journal of immunology"},{"key":"41","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2013-02-485425","article-title":"Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function","volume":"122","author":"Forconi","year":"2013","journal-title":"Blood"},{"key":"42","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","article-title":"The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice","volume":"174","author":"Tedder","year":"2005","journal-title":"Journal of immunology"},{"key":"43","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"Spaargaren","year":"2012","journal-title":"Blood"},{"key":"44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1182\/blood-2009-05-223586","article-title":"A novel Rag2\u2212\/\u2212gammac\u2212\/\u2212-xenograft model of human CLL","volume":"115","author":"Ghia","year":"2010","journal-title":"Blood"},{"key":"45","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","article-title":"CD38 and chronic lymphocytic leukemia: a decade later","volume":"118","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"key":"46","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Croce","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"47","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Burger","year":"2012","journal-title":"Leukemia"},{"key":"48","first-page":"691","article-title":"Translating PI3K-Delta Inhibitors to the Clinic in Chronic Lymphocytic Leukemia: The Story of CAL-101 (GS1101)","author":"Johnson","year":"2012","journal-title":"American Society of Clinical Oncology educational book \/ ASCO American Society of Clinical Oncology Meeting"},{"key":"49","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo","volume":"119","author":"Burger","year":"2012","journal-title":"Blood"},{"key":"50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2004.07.018","article-title":"Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck","volume":"21","author":"Cambier","year":"2004","journal-title":"Immunity"},{"key":"51","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.169.4.1735","article-title":"The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen","volume":"169","author":"Cambier","year":"2002","journal-title":"Journal of immunology"},{"key":"52","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.4049\/jimmunol.164.9.4586","article-title":"A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro","volume":"164","author":"Hardy","year":"2000","journal-title":"Journal of immunology"},{"key":"53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-12-0415-T","article-title":"LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells","volume":"11","author":"Slupsky","year":"2013","journal-title":"Molecular cancer research: MCR"},{"key":"54","first-page":"e51","article-title":"A case of chronic lymphocytic leukemia with massive ascites","volume":"4","author":"Nalcaci","year":"2012","journal-title":"Rare tumors"},{"key":"55","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"56","doi-asserted-by":"crossref","first-page":"22899","DOI":"10.1074\/jbc.M113.449926","article-title":"CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak","volume":"288","author":"Hedin","year":"2013","journal-title":"The Journal of biological chemistry"},{"key":"57","doi-asserted-by":"crossref","first-page":"18359","DOI":"10.1074\/jbc.M112.367060","article-title":"Receptor signaling lymphocyte-activation molecule family 1 (Slamf1) regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting a Beclin-1\/Vps34\/ultraviolet radiation resistance-associated gene (UVRAG) complex","volume":"287","author":"Terhorst","year":"2012","journal-title":"The Journal of biological chemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:05:33Z","timestamp":1594829133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":57,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["8378","27029059"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8378","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}